Altium Capital Management LP Portfolio Holdings

Altium Capital Management LP

  • $283 Million
  • Q3 2024

Altium Capital Management LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $283 Million distributed in 79 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vera Therapeutics, Inc. with a value of $30.2M, Adma Biologics, Inc. with a value of $27.2M, Sarepta Therapeutics, Inc. with a value of $21.2M, Edwards Lifesciences Corp with a value of $14.6M, and Xenon Pharmaceuticals Inc. with a value of $14.2M.

Examining the 13F form we can see an increase of $95.7M in the current position value, from $188M to 283M.

Altium Capital Management LP is based out at New York, NY

Below you can find more details about Altium Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $283 Million
Healthcare: $278 Million
Consumer Cyclical: $3.99 Million
Industrials: $102,000
Financial Services: $2,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$0
$2,000 0.0% of portfolio
100,000
Q1 2023 New
-
$0 0.0% of portfolio
-
Q3 2022 New
Vsee Health Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Better Choice CO Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Biohaven LTD
-
$0 0.0% of portfolio
-
Q3 2024 New
Skye Bioscience Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 2.59%
Scorpius Holdings Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Cybin Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Corbus Pharmaceuticals Hldgs
-
$0 0.0% of portfolio
-
Q3 2024 New
-
$0 0.0% of portfolio
-
Q4 2023 Reduced 85.71%
Contineum Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 14.02%
Conduit Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q3 2023 New
Mobix Labs Inc
-
$0 0.0% of portfolio
-
Q4 2023 New
Coliseum Acquisition Corp
-
$0 0.0% of portfolio
-
Q3 2021 New
$197M
$14,000 0.0% of portfolio
11,419
Q3 2024 New
-
$0 0.0% of portfolio
-
Q3 2022 New
Outlook Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 7.92%
Perspective Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 51.48%
Onfolio Holdings Inc
-
$0 0.0% of portfolio
-
Q3 2022 New
Rocket Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Cellectar Biosciences Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
$0
$7,000 0.0% of portfolio
250,000
Q1 2022 New
Bitcoin Depot Inc
-
$0 0.0% of portfolio
-
Q3 2023 New
Fat Brands Inc
-
$0 0.0% of portfolio
-
Q3 2023 Reduced 11.89%

Summary

  • Portfolio
  • No. of Stocks 79
  • Current Value $283 Million
  • Prior Value $188 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 31 stocks
  • Additional Purchases 7 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 11 stocks
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email